Kim Eun Soo, Tae Chung Hyun, Jung Sung-Ae, Park Dong Il, Im Jong Pil, Eun Chang Soo, Yoon Hyuk, Jang Byung Ik, Ogata Haruhiko, Fukuhara Kayoko, Hirai Fumihito, Ohtsuka Kazuo, Liu Jing, Cao Qian
Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.
Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea.
Intest Res. 2022 Apr;20(2):192-202. doi: 10.5217/ir.2020.00150. Epub 2022 Apr 29.
BACKGROUND/AIMS: Complementary and alternative medicine (CAM) is prevalent in East Asia. However, information on CAM in East Asian patients with inflammatory bowel disease (IBD) is scarce. We aimed to profile the prevalence and pattern of CAM use among East Asian IBD patients and to identify factors associated with CAM use. We also compared physicians' perspectives on CAM.
Patients with IBD from China, Japan, and South Korea were invited to complete questionnaires on CAM use. Patient demographic and clinical data were collected. Logistic regression analysis was applied for predictors of CAM use. Physicians from each country were asked about their opinion on CAM services or products.
Overall, 905 patients with IBD participated in this study (China 232, Japan 255, and South Korea 418). Approximately 8.6% of patients with IBD used CAM services for their disease, while 29.7% of patients sought at least 1 kind of CAM product. Current active disease and Chinese or South Korean nationality over Japanese were independent predictors of CAM use. Chinese doctors were more likely to consider CAM helpful for patients with IBD than were Japanese and South Korean doctors.
In 8.6% and 29.7% of East Asian patients with IBD used CAM services and products, respectively, which does not differ from the prevalence in their Western counterparts. There is a significant gap regarding CAM usage among different Asian countries, not only from the patients' perspective but also from the physicians' point of view.
背景/目的:补充和替代医学(CAM)在东亚地区很普遍。然而,关于东亚炎症性肠病(IBD)患者使用CAM的信息却很少。我们旨在描述东亚IBD患者使用CAM的患病率和模式,并确定与使用CAM相关的因素。我们还比较了医生对CAM的看法。
邀请来自中国、日本和韩国的IBD患者填写关于使用CAM的问卷。收集患者的人口统计学和临床数据。应用逻辑回归分析来确定使用CAM的预测因素。询问每个国家的医生对CAM服务或产品的看法。
总体而言,905例IBD患者参与了本研究(中国232例,日本255例,韩国418例)。约8.6%的IBD患者使用CAM服务来治疗他们的疾病,而29.7%的患者至少寻求过一种CAM产品。当前处于活动期的疾病以及中国或韩国国籍(相对于日本国籍)是使用CAM的独立预测因素。与日本和韩国医生相比,中国医生更倾向于认为CAM对IBD患者有帮助。
分别有8.6%和29.7%的东亚IBD患者使用了CAM服务和产品,这与西方同行的患病率没有差异。不同亚洲国家在CAM使用方面存在显著差距,不仅从患者的角度来看是这样,从医生的角度来看也是如此。